Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2025-01-10

FDA Approved: CHILDRENS FLONASE ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

The FDA approved a supplemental application for Children's Flonase Allergy Relief (fluticasone propionate) by Haleon US Holdings LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHILDRENS FLONASE ALLERGY RELIEF (Fluticasone propionate)

Snippet

SUPPL AP for CHILDRENS FLONASE ALLERGY RELIEF (FLUTICASONE PROPIONATE)